D M Kelly, R J Naylor. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » 5-Hydroxytryptophan/pharmacologyAlkaloids/antagonists & inhibitorsAlkaloids/pharmacologyAnimalsBiogenic Amines/antagonists & inhibitorsBiogenic Amines/metabolismDepression, ChemicalDopamine/pharmacologyDose-Response Relationship, DrugDrug SynergismFenclonine/pharmacologyHallucinogens/antagonists & inhibitorsHallucinogens/pharmacologyHumansIndoles/antagonists & inhibitorsIndoles/pharmacologyMaleMethyltyrosines/pharmacologyParasympatholytics/pharmacologyPyridines/antagonists & inhibitorsPyridines/pharmacologyRatsStatistics as TopicStereotyped Behavior/drug effectsTime FactorsTremor/chemically inducedTremor/metabolism
Substances: See more » AlkaloidsBiogenic AminesHallucinogensIndolesMethyltyrosinesParasympatholyticsPyridines5-HydroxytryptophanFenclonineDopamine
Year: 1974 PMID: 4277567 DOI: 10.1016/0014-2999(74)90197-6
Source DB: PubMed Journal: Eur J Pharmacol ISSN: 0014-2999 Impact factor: 4.432